-
Significantly improve the motor symptoms of patients with Parkinson's disease, phase 2 clinical results are positive
Time of Update: 2021-09-06
The results of the trial showed that compared with placebo, the MDS-UPDRS (a score for evaluating the motor function of patients with Parkinson's disease) in the Anavex 2-73 high-dose group showed a statistically significant improvement .
-
"Speaking" again after 18 years of paralysis and aphasia!
Time of Update: 2021-09-06
The author concluded that for this stroke-induced paralyzed patient with dysarthria, through machine learning and natural language modeling, words and sentences can be decoded in real time based on the cerebral cortex activity collected by the nervous system implant device when the patient tries to speak.
-
Dirui Medical's 2 product medical device registration certificate changes
Time of Update: 2021-09-06
Vaginal secretion analysis test strip (dry chemical method)Change the applicable model to: Applicable to Dirui: automatic gynecological secretion analysis system (model: GMD-S600); vaginal secretion detector (model: GD-S120) .
-
Yiqiao Shenzhou quickly listed Lambda and Delta plus recombinant proteins
Time of Update: 2021-09-05
Molecule label Mutation site 40588-V07E31 N, His P13L, R203K, G204R, G214C 40592-V08H113 RBD, His L452Q, F490S 40589-V08B23 (under development) S1+S2 ECD, His G75V, T76I, R246N, Δ247, Δ253, L452Q, F490S, D614G, T859N 40589-V08B24
-
Delta strain spreads to 17 provinces in China, should we consider long-term coexistence with the virus?
Time of Update: 2021-09-05
If the severe illness rate and death rate have dropped significantly, is it necessary to continue regardless of the cost?A person close to the health care system also revealed to that related people are also considering that the previous epidemic prevention and control strategy has always been from a medical perspective, and experts in social governance and economics should also be introduced in the future .
-
Yangzhou: Support designated hospitals to appropriately increase the amount of medicine prescribed for chronic diseases during the epidemic
Time of Update: 2021-09-05
The Finance Association learned on August 15 that under the gradual escalation of epidemic prevention and control measures in Yangzhou, citizens' medical treatment and purchase of medicines were also affected .
Number of hospital visits and medications .
-
Over 400 million euros, Orion and Alligator Bioscience develop dual-antibody therapy
Time of Update: 2021-09-05
On August 18, Alligator Bioscience announced that the company has signed a research cooperation and licensing agreement with Finland-based Orion Corporation (Orion) to jointly discover and develop new bispecific antibodies (bi-antibody) cancers Therapy .
Source: Alligator Bioscience official websiteReference materials:[1] Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation.
-
Studies have found that drinking green tea may prevent and delay Alzheimer’s
Time of Update: 2021-09-05
The reporter learned from Anhui Agricultural University that Professor Wan Xiaochun of the State Key Laboratory of Tea Biology and Resource Utilization (Anhui Laboratory) of the university, and the research group of Professor Shen Yong of the University of Science and Technology of China, found that green tea can prevent and delay 5XFAD genetic modification.
-
CANCER RES: Abnormal regulation of NEIL3 is associated with poor prognosis of liver cancer
Time of Update: 2021-09-05
The research team collected the tumor and non-tumor tissues of 202 patients with primary liver cancer who underwent hepatectomy from 2010 to 2015, randomly selected 80 pairs of tumors and matched non-tumor specimens, and used immunohistochemical staining to detect NEIL3 expression levels .
-
Junshi Bio-Treplimumab submits its fifth listing application
Time of Update: 2021-09-05
On July 29, Junshi Biotech announced that the National Food and Drug Administration (NMPA) of China has accepted its self-developed anti-PD-1 monoclonal antibody drug teriprizumab combined with platinum-containing chemotherapy for the first-line treatment of locally advanced or metastatic esophageal scales The application for new indications for cancer, this is also the fifth application for the listing of Teriplizumab in China .
-
Professor Tao Sun: Cancer-related fatigue cannot be easily ignored by the clinic
Time of Update: 2021-09-05
After receiving anti-tumor treatment, especially during the interval of chemotherapy, the incidence of this symptom is as high as 70% to 80%, which seriously affects patients Quality of life .
-
Innovent IBI362 clinical research in Chinese overweight or obese subjects published in the Lancet
Time of Update: 2021-09-05
Today, Cinda Biopharmaceuticals announced that the glucagon-like peptide-1 receptor (GLP-1R)/glucagon receptor (GCGR) dual agonist IBI362 has been randomly selected among overweight or obese Chinese subjects.
In the future, it is expected that IBI362 as a multi-target innovative drug in the subsequent phase II clinical studies in overweight/obese subjects will show even more surprising results .
-
Big breasts, more breasts, but small breasts, but no milk?
Time of Update: 2021-09-05
The sucking stimulation of newborns is transmitted to the anterior pituitary through nerve endings to produce prolactin, which is transported to the mammary gland through blood circulation and stimulates the breast to secrete milk .
Most mothers who express breast milk within 6 hours after birth can maintain their lactation time for more than 40 weeks .
-
Anti-obesity gene "one in a million", this therapy is expected to simulate miraculous gene mutations
Time of Update: 2021-09-05
On July 27, 2021, AstraZeneca announced a collaboration with Regeneron to jointly develop and commercialize a new small molecule drug targeting GPR75 to treat obesity and related comorbidities .
Retrieved July 27, 2021, from https:// regeneron-to-research-develop-and-commercialise-new-small-molecule-medicines-for-obesity.
-
Chinese scientists first constructed a mononuclear transcriptome map of primate hippocampus aging
Time of Update: 2021-09-05
There is an area called the hippocampus deep in our brain . It plays a vital role in learning and memory. It gradually degenerates with age and is functionally related to various human neurodegener
-
Pfizer's tick-borne encephalitis vaccine approved in the U.S. for active immunization of people ≥ 1 year old
Time of Update: 2021-09-05
S. Food and Drug Administration (FDA) has approved the tick-borne encephalitis (TBE) vaccine TICOVAC for active immunization of individuals ≥ 1 year old to prevent TBE .
Original source: US FDA Approves TICOVAC™, Pfizer's Tick-Borne Encephalitis (TBE) Vaccine
-
mRNA technology has another success!
Time of Update: 2021-09-05
CompilationTom LeeThis week, Moderna launched a human clinical trial of an AIDS mRNA vaccine .
Moderna to Launch Clinical Trials for mRNA-Based HIV Vaccine2.
Moderna to Trial HIV and Flu Vaccines With mRNA Technology
-
Genxi Biotech and Mingji Biotech reached a new cooperation to develop CLDN18.2 targeted new immunotherapy
Time of Update: 2021-09-05
2 has been regarded as one of the high-quality targets for the development of immune cell therapy, with broad potential for clinical benefit .
2 antibody, to further develop, produce and commercialize innovative immune cells.
-
New cell immunotherapy!
Time of Update: 2021-09-05
▲The anti-tumor mechanism mediated by NK cells (picture source: reference [1])Based on these unique biological characteristics, NK cells have become one of the ideal choices for researchers to develop new immunotherapies .
-
Size doesn't matter: It is difficult to evaluate the efficacy of anticancer drugs when the tumor shrinks
Time of Update: 2021-09-05
Although our understanding of the molecular mechanisms of tumor treatment continues to deepen, the early drug evaluation system still needs a lot of work to improve the prediction of OS, the most critical therapeutic target .
